These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34527093)

  • 21. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal microbiota transplantation for treatment of recurrent or refractory
    Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
    Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Rodrigues J; Sousa M; Sousa I; Carvalho J
    Rev Esp Enferm Dig; 2018 May; 110(5):311-315. PubMed ID: 29411989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
    Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
    Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
    Lee CH; Steiner T; Petrof EO; Smieja M; Roscoe D; Nematallah A; Weese JS; Collins S; Moayyedi P; Crowther M; Ropeleski MJ; Jayaratne P; Higgins D; Li Y; Rau NV; Kim PT
    JAMA; 2016 Jan; 315(2):142-9. PubMed ID: 26757463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
    Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
    J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
    Nicholson MR; Mitchell PD; Alexander E; Ballal S; Bartlett M; Becker P; Davidovics Z; Docktor M; Dole M; Felix G; Gisser J; Hourigan SK; Jensen MK; Kaplan JL; Kelsen J; Kennedy M; Khanna S; Knackstedt E; Leier M; Lewis J; Lodarek A; Michail S; Oliva-Hemker M; Patton T; Queliza K; Russell GH; Singh N; Solomon A; Suskind DL; Werlin S; Kellermayer R; Kahn SA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):612-619.e1. PubMed ID: 31009795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.
    Allegretti JR; Allegretti AS; Phelps E; Xu H; Kassam Z; Fischer M
    Clin Microbiol Infect; 2018 Jul; 24(7):780.e1-780.e3. PubMed ID: 29104169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.
    Rubin TA; Gessert CE; Aas J; Bakken JS
    Anaerobe; 2013 Feb; 19():22-6. PubMed ID: 23182843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation for Clostridium difficile Infection: The Ochsner Experience.
    Ray A; Smith R; Breaux J
    Ochsner J; 2014; 14(4):538-44. PubMed ID: 25598718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
    Reigadas E; Olmedo M; Valerio M; Vázquez-Cuesta S; Alcalá L; Marín M; Muñoz P; Bouza E
    Rev Esp Quimioter; 2018 Oct; 31(5):411-418. PubMed ID: 30221898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
    Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
    Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of
    Tabbaa OM; Aboelsoud MM; Mattar MC
    Gastroenterology Res; 2018 Dec; 11(6):397-403. PubMed ID: 30627262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.
    Goldenberg SD; Batra R; Beales I; Digby-Bell JL; Irving PM; Kellingray L; Narbad A; Franslem-Elumogo N
    Infect Dis Ther; 2018 Mar; 7(1):71-86. PubMed ID: 29450831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
    Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
    Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
    World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.